Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

The annual event offered a space for dialogue between the scientific community and society on how to address the future of ageing through research and innovation.

The event, organized jointly by Vall d’Hebron and the Mayo Clinic, offered specialized talks reviewing the latest developments and challenges in the field of nephrology.

Genetic susceptibility to developing ADHD shows the strongest association with mental health problems during childhood and adolescence, compared to genetic risk for other psychiatric conditions.

Critical thinking enables these professionals to analyse each clinical situation more reflectively and rigorously in order to improve patient care.

 FIT is an initiative aimed at funding projects developed at VHIR with high impact and market transfer potential.

A retrospective study has been carried out with data from 11,000 patients to train artificial intelligence algorithms and adapt the Nora mobile application to different patient profiles.

Transaction expands Formation Bio's immunology pipeline with Phase 1 ready drug candidate.

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

The study, involving a thousand participants from different regions of Spain, shows that diet influences the diversity and composition of the microbiota and, therefore, health.

The project, in which Vall d’Hebron participates, studied the Bimervax® vaccine in immunocompromised individuals and paediatric patients.

The treatment, licensed to Klotho Neurosciences, is based on a technology developed at the Universitat Autònoma de Barcelona (UAB) with the participation of VHIR.

El informe incluye los datos y los resultados científicos e institucionales más destacados del centro durante el año.

The aim of the initiative is to improve the management of innovation projects and their reach to patients and promote innovative and entrepreneurial culture.

ISMED-CLIM is a European project coordinated by the University of Cyprus and has 27 partners from 11 countries, including the Parc Sanitari Pere Virgili and the Vall d'Hebron Research Institute, which lead the regional working group.

The distinction from the Catalan Transplant Society will allow her to become a member of the Royal Academy of Medicine of Catalonia.

PAIR is an intergenerational initiative with people affected by Parkinson's disease and adolescents.

The initiative aims to foster interdisciplinary exchange between social and biomedical sciences, explore innovative ways and generate critical reflection on obstetric violence and ways towards its eradication.

The second edition of the AI ​​Day served to share knowledge, reflect and chart the future of artificial intelligence applied to research and health.

The meetings served to share advances in translational research and consolidate international scientific alliances in the study of liver diseases

The event gathered over 180 attendees, consolidating Vall d’Hebron’s PhD Day as a key space for fostering collaboration in the biomedical field.

The preliminary results of the first cross-sectional study with adolescents and young people aged 11 to 25 in the municipalities of Lobito and Cubal, Angola, show that more than half of the female participants have reported experiencing sexual violence.

The Barcelona Risk Score is a flexible, generalisable clinical tool that will play a key role in selecting the most effective treatment for each person with multiple sclerosis

The study analyzes the impact of COVID-19 on people with rare red blood cell disorders, identifying risk factors for severe forms of the disease.